First evidence about the potential role of LGALS3BP in pancreatic cancer derived from a study by Künzli et al. in which authors analyzed, both at mRNA and protein level the expression and cellular distribution in human pancreatic carcinoma tissues of three ligands for galectin-3, Lamp-1, Lamp-2 (Lysosomal-associated membrane proteins 1–2), and LGALS3BP [47]. This evidence concerns the gene LGALS3BP and pancreatic neoplasm.